falsigra 100 mg tabletki powlekane
polfarmex s.a. - sildenafili citras - tabletki powlekane - 100 mg
falsigra 50 mg tabletki powlekane
polfarmex s.a. - sildenafili citras - tabletki powlekane - 50 mg
allegra d-12 hour- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, extended release
physicians total care, inc. - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 60 mg - allegra-d 12 hour extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. allegra-d 12 hour should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). allegra-d 12 hour is contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, allegra-d 12 hour is contraindicated in patients with narrow-angle glaucoma or urinary retention, and in patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment (see drug interactions section). it is also contraindicated in patients with severe hypertension, or severe coronary arter
allegra-d 24 hour- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated
stat rx usa llc - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 180 mg - allegra-d 24 hour extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. allegra-d 24 hour should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). allegra-d 24 hour is contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, allegra-d 24 hour is contraindicated in patients with narrow-angle glaucoma or urinary retention, and in patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment (see drug interactions section). it is also contraindicated in patients with severe hypertension, or severe co
allegra--d 24 hour- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release
physicians total care, inc. - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 180 mg - allegra-d 24 hour extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. allegra-d 24 hour should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). allegra-d 24 hour is contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, allegra-d 24 hour is contraindicated in patients with narrow-angle glaucoma or urinary retention, and in patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment (see drug interactions section). it is also contraindicated in patients with severe hypertension, or severe coronary arter
allegra
hemofarm ad vrŠac - фексофенадин - film tableta - 120mg
allegra nasal 55 µg/dose susp. pulv. nas. pompe dos.
opella healthcare belgium sa-nv - acétonide de triamcinolone 0,055 g/100 g - suspension pour pulvérisation nasale - 55 µg/dose - acétonide de triamcinolone 0.55 mg/g - triamcinolone
fexallegra 120 mg compresse rivestite con film
sanofi s.p.a. - fexofenadina - compresse rivestite con film - 120 mg - antistaminici per uso sistemico - fexallegra è indicato negli adulti e nei bambini a partire dai 12 anni di età per il trattamento sintomatico della rinite allergica stagionale.
allegra 120 mg
sanofi winthrop industrie - franta - fexofenadinum - compr. film. - 120mg - antihistaminice de uz sistemic alte antihistaminice de uz sistemic
allegra telfast 180 180 mg tabletki powlekane
opella healthcare poland sp. z o.o. - fexofenadini hydrochloridum - tabletki powlekane - 180 mg